Nanovibronix (NAOV) Competitors $0.93 -0.02 (-2.41%) Closing price 07/3/2025 03:45 PM EasternExtended Trading$0.93 +0.00 (+0.11%) As of 07/3/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAOV vs. LYRA, DHAI, IINN, INBS, WOK, PAVM, BTCY, SSKN, NURO, and CODXShould you be buying Nanovibronix stock or one of its competitors? The main competitors of Nanovibronix include Lyra Therapeutics (LYRA), DIH Holding US (DHAI), Inspira Technologies OXY B.H.N. (IINN), Intelligent Bio Solutions (INBS), WORK Medical Technology Group (WOK), PAVmed (PAVM), Biotricity (BTCY), Strata Skin Sciences (SSKN), NeuroMetrix (NURO), and Co-Diagnostics (CODX). These companies are all part of the "medical equipment" industry. Nanovibronix vs. Its Competitors Lyra Therapeutics DIH Holding US Inspira Technologies OXY B.H.N. Intelligent Bio Solutions WORK Medical Technology Group PAVmed Biotricity Strata Skin Sciences NeuroMetrix Co-Diagnostics Nanovibronix (NASDAQ:NAOV) and Lyra Therapeutics (NASDAQ:LYRA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Do analysts prefer NAOV or LYRA? Lyra Therapeutics has a consensus target price of $100.00, indicating a potential upside of 1,009.26%. Given Lyra Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Lyra Therapeutics is more favorable than Nanovibronix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nanovibronix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lyra Therapeutics 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has preferable valuation and earnings, NAOV or LYRA? Nanovibronix has higher revenue and earnings than Lyra Therapeutics. Lyra Therapeutics is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNanovibronix$2.56M0.94-$3.70M-$13.53-0.07Lyra Therapeutics$1.53M7.84-$93.43M-$60.50-0.15 Does the media prefer NAOV or LYRA? In the previous week, Lyra Therapeutics had 1 more articles in the media than Nanovibronix. MarketBeat recorded 1 mentions for Lyra Therapeutics and 0 mentions for Nanovibronix. Lyra Therapeutics' average media sentiment score of 0.75 beat Nanovibronix's score of 0.46 indicating that Lyra Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Nanovibronix Neutral Lyra Therapeutics Positive Which has more volatility and risk, NAOV or LYRA? Nanovibronix has a beta of 1.71, indicating that its share price is 71% more volatile than the S&P 500. Comparatively, Lyra Therapeutics has a beta of 0.24, indicating that its share price is 76% less volatile than the S&P 500. Is NAOV or LYRA more profitable? Nanovibronix has a net margin of -210.82% compared to Lyra Therapeutics' net margin of -6,711.39%. Nanovibronix's return on equity of -54.73% beat Lyra Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Nanovibronix-210.82% -54.73% -38.63% Lyra Therapeutics -6,711.39%-295.52%-66.95% Do insiders & institutionals hold more shares of NAOV or LYRA? 16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 95.6% of Lyra Therapeutics shares are owned by institutional investors. 6.3% of Nanovibronix shares are owned by insiders. Comparatively, 3.3% of Lyra Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryNanovibronix beats Lyra Therapeutics on 9 of the 16 factors compared between the two stocks. Get Nanovibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAOV vs. The Competition Export to ExcelMetricNanovibronixMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.40M$6.86B$5.53B$9.05BDividend YieldN/A1.21%5.24%4.03%P/E Ratio-0.0726.1527.5020.21Price / Sales0.9499.70421.02118.64Price / CashN/A21.0936.8958.07Price / Book0.514.748.045.67Net Income-$3.70M$173.18M$3.18B$249.13M7 Day Performance-20.43%1.33%2.82%3.30%1 Month Performance-10.48%-0.41%3.70%5.20%1 Year Performance-88.05%28.42%35.41%21.38% Nanovibronix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAOVNanovibronix0.2883 of 5 stars$0.93-2.4%N/A-88.1%$2.40M$2.56M-0.0720LYRALyra Therapeutics2.3118 of 5 stars$8.96-1.6%$100.00+1,016.1%-35.6%$12.07M$1.53M-0.1550DHAIDIH Holding US0.7083 of 5 stars$0.24-2.4%N/A-92.1%$11.88M$64.47M-0.82N/AGap DownIINNInspira Technologies OXY B.H.N.2.8688 of 5 stars$0.85flat$2.00+135.3%-9.6%$10.73MN/A0.0020INBSIntelligent Bio Solutions0.3303 of 5 stars$1.72+12.4%N/A+1.1%$10.57M$3.11M0.0010WOKWORK Medical Technology GroupN/A$0.69-3.5%N/AN/A$10.43M$11.51M0.00226Gap UpPAVMPAVmed3.9591 of 5 stars$0.60+0.1%$19.00+3,065.1%-15.7%$10.26M$2.99M0.8590BTCYBiotricityN/A$0.37-7.9%N/A-46.5%$10.02M$12.06M-0.3440News CoverageGap DownSSKNStrata Skin Sciences2.8805 of 5 stars$2.29+1.8%$6.00+162.0%-23.2%$9.39M$33.56M-1.01120NURONeuroMetrixN/A$4.55+4.4%N/A+22.0%$9.37M$3.03M-0.9920High Trading VolumeCODXCo-Diagnostics4.2089 of 5 stars$0.28+6.7%$5.50+1,862.9%-77.6%$8.81M$3.91M-0.24100Gap Up Related Companies and Tools Related Companies Lyra Therapeutics Competitors DIH Holding US Competitors Inspira Technologies OXY B.H.N. Competitors Intelligent Bio Solutions Competitors WORK Medical Technology Group Competitors PAVmed Competitors Biotricity Competitors Strata Skin Sciences Competitors NeuroMetrix Competitors Co-Diagnostics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAOV) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.The robotics revolution is here. And it's set to impact everything from how we manufacture goods to how we ...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanovibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanovibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAOV Stock Alerts